Skip to main content
Fig. 2 | Journal of Translational Medicine

Fig. 2

From: Prevention of neointimal hyperplasia after coronary artery bypass graft via local delivery of sirolimus and rosuvastatin: network pharmacology and in vivo validation

Fig. 2

Intersection of potential targets of CABG, sirolimus, and rosuvastatin along with overlapping targets in a drug-disease network. A Venn diagram showing the potential targets of CABG, sirolimus, and rosuvastatin. Yellow section represents the potential targets of CABG, blue section represents the potential targets of sirolimus, and pink section represents the potential targets of rosuvastatin. B Overlapping targets in the drug-disease network. CABG, coronary artery bypass graft

Back to article page